Close

Double your impact Match My Donation

The Cancer Research Institute Associate Board is a group of young leaders dedicated to CRI and its mission to advance cancer immunotherapy research. Members provide invaluable professional expertise and utilize their diverse talents to develop social events, assist with fundraising initiatives, and cultivate individual and corporate relationships.

Chairman
Trent Kososki
Chairman
Members
Adler Bernard
Board Member
Ross Bruck
Board Member
Rada Cevher
Board Member
Robert W. Chen
Board Member
Eash Cumarasamy
Board Member
Isabelle Franks
Board Member
Andrew Goldman
Board Member
Matt Goldman
Board Member
Jack Griffin
Board Member
Tyler Hassen
Board Member
Samantha Knapik
Board Member
Jennifer Kososki
Board Member
Pär Lindstrom
Taylor Paul
Board Member
Tomas Peshkatari
Board Member
Philip Shapiro
Board Member
Courtney Shields
Board Member
Josh Tinch
Board Member
Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link

*Immunotherapy results may vary from patient to patient.

Contact Us

Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111

(800) 992-2623(212) 832-9376Staff Directory

Stay Connected with CRI

Follow us

Recent Blog Posts

Patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, can now receive PD-1 immunotherapy for treatment.

Sixteen Team CRI runners ran the 26.2 mile 2018 TCS New York City Marathon and raised an impressive total of $110,000.
Top